Immunotherapy of peritoneal carcinomatosis with the antibody catumaxomab in colon, gastric, or pancreatic cancer: an open-label, multicenter, phase I/II trial.
Immunotherapy of peritoneal carcinomatosis with the catumaxomab antibody in colon, stomach or pancreatic cancer: an open-label, multicenter, phase I / II trial.